LONDON - As the International AIDS Conference continues in Germany, activists are calling for action to break monopoly on lenacapavir.
They want the groundbreaking HIV prevention drug made affordable for all.
Researchers say lenacapavir could be life-changing for people at risk of getting HIV.
Dr Jake Levi, Researcher for MetaVirology, spoke to eNCA on this topic.